These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8030829)

  • 1. Age dependence of the glutamate antagonistic effect of GYKI 52466 in snail neurons.
    Tarnawa I; Tóth S; Sármány J; Pénzes I
    Ann N Y Acad Sci; 1994 Jun; 717():129-36. PubMed ID: 8030829
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection against non-NMDA receptor-mediated excitotoxicity by GYKI 52466 in mature telencephalic cultures of the rat.
    Kovács AD; Egyed A
    Neurobiology (Bp); 1996; 4(1-2):59-72. PubMed ID: 9116695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of kainate-induced responses by pentobarbitone and GYKI-53784 in rat abducens motoneurons in vivo.
    Ruiz A; Durand J
    Brain Res; 1999 Feb; 818(2):421-30. PubMed ID: 10082828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPA-preferring receptors mediate excitatory synaptic inputs to retinal ganglion cells.
    Lukasiewicz PD; Wilson JA; Lawrence JE
    J Neurophysiol; 1997 Jan; 77(1):57-64. PubMed ID: 9120596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
    Donevan SD; Yamaguchi S; Rogawski MA
    J Pharmacol Exp Ther; 1994 Oct; 271(1):25-9. PubMed ID: 7525924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
    Johansen TH; Chaudhary A; Verdoorn TA
    Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
    Wilding TJ; Huettner JE
    Mol Pharmacol; 1995 Mar; 47(3):582-7. PubMed ID: 7700255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1995; 47(6):501-7. PubMed ID: 8868372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diazepam dependence prevented by glutamate antagonists.
    Steppuhn KG; Turski L
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6889-93. PubMed ID: 8341715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsynaptic responses of horizontal cells in the tiger salamander retina are mediated by AMPA-preferring receptors.
    Yang JH; Maple B; Gao F; Maguire G; Wu SM
    Brain Res; 1998 Jun; 797(1):125-34. PubMed ID: 9630565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GYKI 52466 and CNQX, AMPA/kainate receptor antagonists, on the micturition reflex in the rat.
    Yoshiyama M; Roppolo JR; de Groat WC
    Brain Res; 1995 Sep; 691(1-2):185-94. PubMed ID: 8590052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained ethanol inhibition of native AMPA receptors on medial septum/diagonal band (MS/DB) neurons.
    Frye GD; Fincher A
    Br J Pharmacol; 2000 Jan; 129(1):87-94. PubMed ID: 10694206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of action of GYKI 52466 and its analogues in antiepileptic, anti-ischaemic and muscle relaxant tests.
    Szabados T; Gigler G; Gyertyán I; Gacsályi I; Lévay G
    Neurobiology (Bp); 1999; 7(1):87-8. PubMed ID: 10746257
    [No Abstract]   [Full Text] [Related]  

  • 15. Pretreatment but not posttreatment with GYKI 52466 reduces functional deficits and neuronal damage after global ischemia in rats.
    Block F; Schmitt W; Schwarz M
    J Neurol Sci; 1996 Aug; 139(2):167-72. PubMed ID: 8856648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
    Yamada KA; Turetsky DM
    Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hippocampal field potentials by GYKI 52466 in vitro and in vivo.
    Tarnawa I; Molnár P; Gaál L; Andrási F
    Acta Physiol Hung; 1992; 79(2):163-9. PubMed ID: 1363929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of GYKI 52466 on AMPA-induced neurotoxicity in rat striatum.
    Bartha E; Lovas G; Szentkuty E; Horváth EJ; Palkovits M
    Neurobiology (Bp); 1998; 6(2):127-39. PubMed ID: 9785349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflex inhibitory action of a non-NMDA type excitatory amino acid antagonist, GYKI 52466.
    Tarnawa I; Farkas S; Berzsenyi P; Pátfalusi M; Andrási F
    Acta Physiol Hung; 1990; 75 Suppl():277-8. PubMed ID: 2371888
    [No Abstract]   [Full Text] [Related]  

  • 20. Ca2+-permeable non-NMDA glutamate receptors in rat magnocellular basal forebrain neurones.
    Waters DJ; Allen TG
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):453-69. PubMed ID: 9508809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.